German pharmaceutical company Stada has signed a medical cannabis supply agreement with Barrie, Ontario-headquartered MediPharm Labs, the Canadian company announced Monday. In exchange, Stada will commercialize the cannabis products, initially in Germany, according to the press release. Bad Vilbel, Germany-based Stada says its products are sold in approximately 120 countries. A MediPharm spokesperson said the company expects its first products to be available in the German market “early next year.” The spokesperson confirmed the deal is binding but declined to discuss quantities. MediPharm received its first GMP certification last December – a quality certification that is required to market medical cannabis extracts in Europe.

Marijuana Business Daily, 10/07/2020 12:31:41

Open article: